Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
The sustainability of Thursday's recovery is the key to watch, as frontline indices remained well below short-term moving averages. Below are some short-term trading ideas to consider.
Procter & Gamble Health shares had a robust gap up opening on Monday, rising nearly 15 percent to Rs 4,703, the highest closing level since February 16, 2022. In fact, the gap up opening has helped the stock climb over all long term moving averages (50, 100 and 200 EMA). The stock has formed strong bullish candlestick pattern on the daily charts with healthy volumes.
In 2019 so far, the Sensex and Nifty rallied 10 percent each while the BSE Midcap index fell 3 percent and Smallcap index lost 1 percent.
Rajesh Agarwal of AUM Capital recommends buying UPL with stop loss at Rs 669 and target of Rs 695, Yes Bank with stop loss at Rs 359 and target of Rs 375 and SRF with stop loss at Rs 2000 and target of Rs 2120.
There was a lot of stock specific action in the small, mid and largecaps which kept traders busy in last week.
"The Fed even is neutral to positive for the markets for the following reasons. a) relief that only two hikes are expected this year, and b) surprisingly the inflation number has not been revised upwards," VK Sharma, Head PCG and Capital Market Strategy at HDFC Securities told Moneycontrol.
We advise investors to avoid creating aggressive shorts at the current juncture and instead look to accumulate quality stocks in a staggered manner for the medium-term.
Aashish Tater of FortuneWizard.com is of the view that Merck may move to Rs 1500.
In an interview to CNBC-TV18 pharma analyst, Anmol Ganjoo of Antique Stock Broking said Delhi High court's verdict on Januvia Generic will be a positive for Glenmark Pharma.
In CNBC-TV18's popular show Bull's Eye, Abhishek Agarwal, Fortune Interfinance shares trading strategy of the day.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Buy Merck with long term perspective, says Aashish Tater, Head of Research, Fort Share Broking.
Merck is a good long-term stock, says Rajen Shah, CIO Angel Broking.